Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Innospace's rocket crashes in first commercial launch in Brazil; shares tumble - 2Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- 3Accor signs agreement to transform El Gouna resort as Sofitel
- 4Whale stranded in the Baltic Sea swims free again. It still faces a tough task
- 5Insane Realities That Will Make You Reconsider How you might interpret History
- Germany's Pistorius: NATO protects Europe from Iranian missiles
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- 8 Espresso Bean Starting points All over the Planet
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- Seoul says sorry after unapproved drone flights into North Korea
- Nature: 10 High priority Setting up camp Spots In Europe
- The best movies to watch this holiday season: Stream 'A Christmas Story Christmas,' revisit 'The Night Before' and discover 'The Baltimorons'
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- When fake data is a good thing – how synthetic data trains AI to solve real problems
